The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted ...

Investing.com -- Verastem Inc (NASDAQ:VSTM) stock dropped 3.4% in after-hours trading Monday following the company’s announcement that it will discontinue its RAMP 203 clinical trial in advanced KRAS ...

The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...

Women under 50, even those who don’t smoke, are seeing a rise in lung cancer cases. Oncologist stresses recognising warning ...

In July, the FDA issued a complete response letter (CRL) for Replimune's biologics license application for RP1 (vusolimogene ...

Top articles in non–small cell lung cancer (NSCLC) include FDA approvals, improved outcomes due to certain treatments, and ...

The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

The clinic will use artificial intelligence and genetic screening to detect and treat serious diseases such as cancer and ...

Oncology announced that following evaluation of interim data from the RAMP 203 clinical trial in advanced KRAS G12C-mutated ...

Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...